Clinical Trial Update: A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing treatment in patients with Waldenstrom's Macroglobulinemia or Multiple Myeloma; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Waldenström Macroglobulinemia

Snippet

Sponsor: Eli Lilly and Company | Conditions: Waldenstrom's Macroglobulinemia, Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2020-09-03